Study Stopped
no participants enrolled
Quantifying tACS-driven Improvement of Working Memory in Depression
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
TACS is an emergent method of non-invasive neuromodulation which can engage frequency-specific brain oscillations. It is increasingly recognized that neural oscillations play a system-organizing role in the brain. Evidence suggests that disorganized neural oscillations may also influence functionality of cognitive processes such as working memory. Thus, as TACS can affect neural oscillatory activity in the human brain in a non-invasive manner, it has promise to transform mental health care. The premise of this proposed work is that tACS concurrent with multi-session working memory (WM) focused skills will facilitate durable working memory and stabilized neural oscillations. Depression offers an excellent model to study the effects of tACS. The study seeka to administer 2mA of tACS using theta oscillations to improve working memory concerns associated with depression. The purpose of this study is to investigate the electrophysiological and behavioral effects of transcranial alternating current stimulation (tACS) in humans and to explore specific improvements in working memory and depressive symptoms. This study is placebo-controlled study. Participants will undergo pre- and post-assessments and either theta or sham tACS for 5 days. During each session, the volunteer will perform cognitive tasks while receiving tACS. Assessment sessions will include cognitive tasks, questionnaires, a clinical interview, and EEG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2023
Shorter than P25 for not_applicable depression
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2023
CompletedFirst Submitted
Initial submission to the registry
October 16, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2024
CompletedSeptember 23, 2024
September 1, 2024
12 months
October 16, 2023
September 19, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
working memory skills
Using a cognitive task that will consist of test responses (correct / incorrect) and reaction time (in ms). The task will include looking at faces expressing different emotions and matching them with previous images.
Day 5
Resting state EEG
examine theta power and connectivity with the EEG recordings
Day 6
Resting state EEG
examine theta power and connectivity with the EEG recordings
Day 35
task-based EEG
examine theta power and connectivity with the EEG recordings
Day 6
task-based EEG
examine theta power and connectivity with the EEG recordings
Day 35
Study Arms (2)
control group
SHAM COMPARATORparticipants with depressive disorder
Active group
EXPERIMENTALparticipants with depressive disorder
Interventions
The low intensity transcranial electrical stimulation will be administered with a battery-powered, current-controlled, multi-channel stimulator from Neuroelectrics® Starstim 8. This device comes with a neoprene headcap to hold the electrodes in place. TACS will be delivered concurrently with the task. The multichannel, current-driven stimulator (Neuroelectrics StarStim 8) will be used to control independent stimulation electrodes on the scalp of the volunteer. The stimulation intensity will be up to 2 mA.
A placebo control stimulation will use an identical montage to the stimulation montage. However, polarities of the electrodes will be such that only a minimal amount of current reaches the brain, which is achieved through controlled current shunting between neighboring electrodes. This so-called ActiSham protocol is a verified method to imitate the sensations of actual tACS, with minimal stimulation of the brain .
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years old.
- Stated willingness to participate and comply with all study procedures.
- Stated availability for the duration of the study.
- Meet criteria for Major Depressive Disorder.
- Agreement to adhere to lifestyle considerations throughout study duration.
- No conflict of interest with the Department of Biomedical Engineering at the University of Minnesota.
- Confident level of English language.
You may not qualify if:
- History or evidence of chronic neurological disorder (e.g., history of seizures, epilepsy, unexplained episodes of loss of consciousness, serious brain injury, severe or frequent headaches)
- Metal or electric implant in the head, neck or chest area.
- Implanted pacemakers or other electrically, magnetically, ir mechanically activated implant
- Vascular clips or other electrically sensitive support systems in the brain
- Serious health conditions (e.g., congestive heart failure pulmonary obstructive chronic disease, active neoplasia)
- History of head injuries.
- Pregnancy or breast-feeding.
- Significant damage of skin at sites of stimulation or other skin concerns, such as dermatitis, psoriasis, or eczema
- Alcohol or drug addiction.
- Any legal reason why the candidate cannot participate.
- Concurrent enrollment in another scientific or clinical study.
- Estimated IQ is below 70, defined by the WTAR.
- Active suicidality or other non-controlled neuropsychiatric illness. Active suicidality will be excluded based on a C-SSRS score of 3 or above in the last 6 months. Severe depression is defined as a PHQ-9 score above 20, which will also be excluded.
- A lifetime suicide attempt.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Opitz, PhD
University of Minnesota
- PRINCIPAL INVESTIGATOR
Kelvin Lim, MD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2023
First Posted
November 1, 2023
Study Start
September 5, 2023
Primary Completion
August 16, 2024
Study Completion
August 16, 2024
Last Updated
September 23, 2024
Record last verified: 2024-09